We are assembling a dynamic team who are passionate about realising the potential of the ground-breaking SINEUP® technology.
Sarah joins Transine Therapeutics after co-leading the seed-funding of the company as a Partner in TVI. Sarah has over 15 years’ experience in preclinical research in both UK and USA-based organisations. With a specialist interest in Neuroscience research, Sarah has held a number of senior management positions within big pharma, and junior faculty and visiting Professorship positions in academia. Over the course of her career, Sarah has established high calibre multidisciplinary teams and strategic academic collaborations. Sarah holds a PhD in Pharmacology from the University of Cambridge.
Cintia joins Transine Therapeutics from Takeda Ventures, having worked in senior level executive support for over 10 years. Previously working for blue chip companies including Loreal, Pfizer and Unilever, Cintia’s experience ranges from high level executive support to office management, procurement and operations. Cintia has a bachelor’s degree in business and Administration from San Francisco University Sao Paulo, Brazil.
Emmanuelle joins the team from the Wellcome Sanger Institute and brings with her 15 years’ experience in sourcing, managing, developing, and partnering IP. Emmanuelle has significant business development experience in forging industrial collaboration around innovation and in commercialisation of genomic research, for which she was named one of the Movers and Shakers of BioBusiness 2020. Emmanuelle holds a PhD in Immunology from the Pasteur Institute, Paris.
An expert cell biologist, Marc has over 18 years’ worth of experience in CNS biology and in vitro cell models. During this time, he has worked in academic, biotech and global pharmaceutical environments and has significant leadership experience focused on discovery projects ranging from pre-clinical to candidate selection stages. With experience in small molecules and biologics, Marc has significant collaborative experience with external partners, delivery key project data from CROs and academic labs. Marc holds a PhD in Neuroscience from the University of Manchester.
Ana is a highly proficient cell biologist with 10 years’ experience working in biotech, being integral to driving and executing laboratory activities both in early stage and lead projects up to candidate selection stages. Before joining the team, Ana worked at Mission Therapeutics where she led in vitro and in vivo work packages to enable clinical development of small molecule inhibitors targeting mitochondrial dysfunction. Ana has significant research experience in a range of therapeutic areas including Oncology and Neuroscience. Ana holds a PhD in Developmental Biology from the University of Sheffield.
Laura joins the team from Cell Guidance Systems, where she deployed her significant research capabilities to develop key assays for SINEUP evaluation. With a strong background in Neuroscience, Laura undertook a Postdoctoral Fellowship at the MRC Laboratory of Molecular Biology, Cambridge. Laura has extensive experience in specialized tissue culture, together with an impressive track record in the detailed characterization of in vivo model of CNS disease. Laura gained her PhD in Cellular and Molecular Biology from the University of Dundee.